Actinium Pharmaceuticals (ATNM) Capital Leases (2018 - 2025)
Actinium Pharmaceuticals (ATNM) recorded Capital Leases of $2,000 in Q3 2025, down 83.3% from $12,000 a year earlier and down 60.0% from the prior quarter.
Powered by 
Analysis
Actinium Pharmaceuticals (ATNM) Capital Leases (2018 - 2025) Analysis & Trends
At the end of FY2024, Actinium Pharmaceuticals reported Capital Leases of $9,000, down 52.6% from FY2023.
- Annual Capital Leases has a three-year compound annual growth rate of 44.2% (FY2021 to FY2024).
- Across earlier years, Capital Leases came in at $19,000 in FY2023 and $3,000 in FY2021.
- The Q3 2025 figure is the lowest quarterly Capital Leases since Q3 2022.
- On a year-over-year basis, Capital Leases has declined for four consecutive quarters, with an average decline of 64.8% over the last four quarters.
- Per Business Quant, the preceding three quarters came in at $5,000 (Q2 2025), $7,000 (Q1 2025) and $9,000 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Actinium Pharmaceuticals | 49.05 Mn | -130.95 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 5,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Dec 31, 2023 | 19,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Jun 30, 2022 | 2.34 Mn |
| Mar 31, 2022 | 2,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 4,000.00 |
| Jun 30, 2021 | 20,000.00 |
| Mar 31, 2021 | 43,000.00 |
| Dec 31, 2020 | 66,000.00 |
| Sep 30, 2020 | 87,000.00 |
| Jun 30, 2020 | 109,000.00 |
| Mar 31, 2020 | 130,000.00 |
| Dec 31, 2019 | 151,000.00 |
API Access
Actinium Pharmaceuticals Capital Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-leases&ticker=ATNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-leases", "ticker": "ATNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-leases&ticker=ATNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();